Global Auto-injectors Market: Snapshot

The global auto-injectors market is growing at a healthy pace and is predicted to witness a promising growth in the next few years. The emerging economies, across the globe, are likely to offer lucrative growth opportunities for the market players in the next few years. The rising use of biologics and the increasing incidence of chronic ailments are predicted to enhance the growth of the global auto-injectors market in the next few years.

global-auto-injectors-market

According to the market research study by Transparency Market Research, in 2013, the global market for auto-injectors was worth US$665.0 mn and is projected to reach a value of US$2.5 bn by the end of 2020. Furthermore, the market is estimated to register a strong 18.60% CAGR between 2014 and 2020.

Advancements and Innovations to Encourage Market Growth in Coming Years

The increasing incidence of rheumatoid arthritis and the rising food allergies are the key factors that are estimated to encourage the growth of the global auto-injectors market in the next few years. The rising research and development activities and the advancements in the medical sector are further projected to accelerate the growth of the market in the near future. On the flip side, the high price of auto-injectors is projected to restrict the growth of the global market in the coming few years. Nevertheless, the rising disposable income of consumers in developing nations is expected to support the growth of the overall market in the coming years. 

The global auto-injectors market has been categorized on the basis of product type into fillable auto-injectors and prefilled auto-injectors. Among these, the prefilled auto-injectors segment is expected to account for a large share of the market in the next few years. The rising awareness among patients and the ease of use are the key factors that are estimated to accelerate the growth of this segment in the next few years. Furthermore, on the basis of manufacturing design, the global auto-injectors market has been divided into customized auto-injectors and standardized auto-injectors. The standardized auto-injectors segment is predicted to lead the market in the next few years; however, the customized auto-injectors segment is predicted to register a strong growth in the coming years.

North America to Remain Dominant in Global Auto-injectors Market

The global market for auto-injectors has been categorized on the basis of geography into Asia Pacific, Latin America, North America, Europe, and the Middle East and Africa. In the last few years, North America led the global auto-injectors market and is expected to remain in the similar position in the coming few years. The favorable government reimbursement policies and the presence of several key players are the major factors that are estimated to enhance the growth of the auto-injectors market across North America in the next few years. On the flip side, Asia Pacific is projected to witness a strong growth in the next few years, thanks to the rising awareness among consumers regarding the advanced treatment methods that are available in the market.

The global market for auto-injectors is consolidated in nature with a few players holding a major share of the market. The key players in the market are focusing on the development of new product and innovations in order to maintain their dominance across the globe. In addition to this, the rising research and development activities is projected to accelerate the growth of the overall market in the next few years. Some of the leading players operating in the auto-injectors market across the globe are Antares Pharma, Inc., Pfizer, Inc., Becton, Dickinson and Company, Unilife Corporation, Mylan, Inc., Ypsomed Holdings AG., Novartis International AG, Biogen Idec, Inc., and Sanofi.

 
Auto-injectors are used for the administration of a single dose of a particular (typically life-saving) drug. They are designed for easy use and intended for self administration or administration by any untrained personnel. 
 
This report provides an in-depth analysis of the global auto-injectors market. The stakeholders for this report include companies engaged in research and development, manufacturing, distribution, and commercialization of auto-injectors, and new entrants planning to invest in the auto-injectors market. The executive summary section of this report provides a snapshot of the auto-injectors market, which summarizes the market size, trends, and competition for different types of auto-injectors for various therapeutic applications on the global front.
 
The market overview section elucidates market dynamics such as drivers, restraints, and opportunities that currently have strong influence over the auto-injectors market and could impact the future scenario of the market as well. Market attractiveness analysis has been included in the market overview section in order to explicate the degree of competition among major geographies. 
 
Porter’s five forces analysis is also incorporated in this section to explore the overall competition in the auto-injectors market, considering five different parameters that have an effect on the sustainability of companies in the market. The regulatory framework section highlights the standards and recommendations, set by various government organizations worldwide, which have strong impact on the auto-injectors market. Competition between major market players is analyzed along with their market share analysis in the competitive landscape section of the report. Value chain analysis has been provided to recognize the value-creating activities from a number of processes that take place in transforming inputs to valuable outputs. Event mapping is done for a brief understanding of the technological advancements, new product launches, and strategic decisions taken by players in the global auto-injectors market. All these factors assist the market players in taking strategic decisions, which help them in escalating their market share and strengthening their positions in the global auto-injectors market.
 
The global auto-injectors market has been segmented on the basis of product, therapeutic applications, and manufacturing design. Based on product type, the global auto-injectors market is classified into two major segments, namely prefilled auto-injectors and fillable auto-injectors. Based on therapeutic applications, the auto-injectors market is differentiated into four segments: anaphylaxis, multiple sclerosis, rheumatoid arthritis, and others. Depending upon the manufacturing design, the global auto-injectors market is categorized into two segments: standardized auto-injectors and customized auto-injectors. Market revenue in terms of USD million for the period between 2012 and 2020 along with the compound annual growth rate (CAGR %) from 2014 to 2020 are provided for all segments, considering 2013 as the base year. 
 
Geographically, the global auto-injectors market has been segmented into four regional markets: North America, Europe, Asia Pacific, and Rest of the World (RoW). This section of the report provides market estimations in terms of revenue (USD million) of auto-injectors across four regions from 2012 to 2020. CAGR % for the period from 2014 to 2020 is also analyzed for these four geographies, considering 2013 as the base year.
 
This report also includes recommendations that would help new market entrants in establishing presence and existing market players in expanding their global reach and market share in the auto-injectors market. The report concludes by profiling major players in the auto-injectors market. Company overview, financial overview, product portfolio, business strategy, and recent developments are provided for major market players in the company profile section. Major market players profiled in the report include Antares Pharma, Inc., Becton, Dickinson and Company, Biogen Idec, Inc., Mylan, Inc., Novartis International AG, Pfizer, Inc., Sanofi, Scandinavian Health Limited (SHL) Group, Unilife Corporation, and Ypsomed Holdings AG.
 
The global auto-injectors market has been segmented into the following categories:
 
Global Auto-Injectors Market, by Product Type 
  • Prefilled (Disposable) Auto-injectors
  • Fillable (Reusable) Auto-injectors
Global Auto- Injectors Market, by Therapeutic Application
  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others
Global Auto-Injectors Market, by Product Type
  • Standardized Auto-injectors
  • Customized Auto-injectors
Global Auto-Injectors Market, by Geography
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Auto-injectors Market
2.2 Comparative Analysis: Global Auto-injectors Market, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Global Auto-injectors Market Overview
3.1 Introduction
3.2 Market Dynamics
      3.2.1 Market Drivers
              3.2.1.1 Rising Prevalence of Anaphylaxis in Developed Countries is Increasing the Demand for Epinephrine Auto-injectors
              3.2.1.2 Favorable Reimbursement Policies are Encouraging Patients to Opt for Auto-injectors
              3.2.1.3 Efforts by Government Bodies and Market Players to Increase Awareness about the Use and Efficacy of Auto-injectors
      3.2.2 Market Restraints
              3.2.2.1 High Product Prices Restrict Patients in Emerging Economies from Purchasing Auto-injectors
      3.2.3 Market Opportunities
              3.2.3.1 High Prevalence of Food Allergies and Rheumatoid Arthritis in Emerging Economies would Drive the Demand for Auto-injectors in Asia Pacific and RoW markets
3.3 Regulatory Framework: Global Auto-injectors Market
3.4 Event Impact Analysis: Global Auto-injectors Market
3.5 Value Chain Analysis: Global Auto-injectors Market
3.6 Porter’s Five Forces Analysis: Global Auto-injectors Market
      3.6.1 Bargaining Power of Suppliers
      3.6.2 Bargaining Power of Buyers
      3.6.3 Threat of Substitutes
      3.6.4 Threat of New Entrants
      3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis: Global Auto-injectors Market, by Geography
3.8 Competitive Landscape
      3.8.1 Market Share Analysis: Global Standardized Auto-injectors Market, by Key Players, 2013 (Value %)
 
Chapter 4 Global Auto-injectors Market, by Product Type
4.1 Introduction
4.2 Prefilled (Disposable) Auto-injectors
      4.2.1 Global Prefilled Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
4.3 Fillable (Reusable) Auto-injectors
      4.3.1 Global Fillable Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 5 Global Auto-injectors Market, by Manufacturing Design
5.1 Introduction
5.2 Standardized Auto-injectors
      5.2.1 Global Standardized Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
5.3 Customized Auto-injectors
      5.3.1 Global Customized Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 6 Global Auto-injectors Market, by Therapeutic Application
6.1 Introduction
6.2 Anaphylaxis
      6.2.1 Global Anaphylaxis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
6.3 Multiple Sclerosis
      6.3.1 Global Multiple Sclerosis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
6.4 Rheumatoid Arthritis
      6.4.1 Global Rheumatoid Arthritis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
6.5 Others
      6.5.1 Global Others Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 7 Global Auto-injectors Market, by Geography
7.1 Introduction
7.2 North America
      7.2.1 North America Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
7.3 Europe
      7.3.1 Europe Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
7.4 Asia Pacific
      7.4.1 Asia Pacific Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
7.5 Rest of the World (RoW)
      7.5.1 Rest of the World Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 8 Recommendations
8.1 Invest in Emerging Economies such as India and China
8.2 Investing in Marketing Campaigns to Elevate Customer Awareness
8.3 Developing Innovative Auto-injectors
 
Chapter 9 Company Profiles
9.1 Antares Pharma, Inc.
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Becton, Dickinson & Company
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Biogen Idec
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 Mylan, Inc.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Novartis International AG
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 Pfizer, Inc.
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 Sanofi
      9.7.1 Company Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 Scandinavian Health Ltd (SHL) Group
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 Unilife Corporation
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 Ypsomed Holding AG
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies
      9.10.5 Recent Developments
List of Tables
 
TABLE 1 Market Snapshot: Global Auto-injectors Market
TABLE 2 Global Auto-injectors Market Revenue, by Product Type, 2012 – 2020 (USD Million)
TABLE 3 Global Auto-injectors Market Revenue, by Manufacturing Design, 2012 – 2020 (USD Million)
TABLE 4 Major Auto-injectors Brand with Therapeutic Applications
TABLE 5 Global Auto-Injectors Market Revenue, by Therapeutic Application, 2012 – 2020 (USD Million)
TABLE 6 Global Auto-injectors Market Revenue, by Geography, 2012 – 2020 (USD Million)
List of Figures
 
FIG. 1 Auto-injectors Market Segmentation
FIG. 2 Global Auto-injectors Market, by Product Type and by Manufacturing Design, 2013 (USD Million)
FIG. 3 Global Auto-injectors Market, by Therapeutic Applications, 2013 (USD Million)
FIG. 4 Comparative Analysis: Global Auto-injectors Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Value Chain Analysis: Global Auto-injectors Market
FIG. 6 Porter’s Five Forces Analysis: Global Auto-injectors Market
FIG. 7 Market Attractiveness Analysis: Global Auto-injectors Market, by Geography
FIG. 8 Market Share Analysis: Global Standardized Auto-injectors Market, by Key Players, 2013 (Value %)
FIG. 9 Global Prefilled Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 10 Global Fillable Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Global Standardized Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 Global Customized Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 Global Anaphylaxis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Global Multiple Sclerosis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 Global Rheumatoid Arthritis Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 Global Others Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 North America Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 Europe Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Asia Pacific Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Rest of the World Auto-injectors Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 Antares Pharma, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 22 Becton, Dickinson & Company: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 23 Biogen Idec: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 24 Mylan, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 25 Novartis International AG: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 26 Pfizer, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 27 Sanofi: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 28 Unilife Corporation: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 29 Ypsomed Holding AG: Annual Revenue, 2011 – 2013 (USD Million)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Global Auto Injectors Market